BioStock: 10 advantages of Stayble’s treatment

Stayble Therapeutics’ injectable and lactic acid-based drug candidate STA363 triggers a connective tissue transformation in the spinal disc, which is expected to provide long-term pain relief for patients with discogenic chronic low back pain. BioStock deep dive into the benefits of STA363.

Read the full article at biostock.se:

https://www.biostock.se/en/2022/06/10-advantages-of-staybles-treatment/

This is a press release from BioStock - Connecting Innovation & Capital. https://www.biostock.se